Search results for "Opioids"
Dabigatran recalled, dense-breast notification required
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/05/dabigatran-recalled-dense-breast-notification-required.htm
1 May 2023
MKSAP Quiz: Increased frequency of long-term headaches
This week's quiz asks readers to determine the most appropriate next step in treatment for a 48-year-old man with a 25-year history of headaches that have become increasingly frequent.
https://immattersacp.org/weekly/archives/2023/04/18/3.htm
18 Apr 2023
ACP resources can help fulfill new DEA training requirement on substance use disorders
Starting June 27, 2023, the Drug Enforcement Administration (DEA) will require registered physicians to provide a one-time attestation that they have completed eight hours of training, and ACP's education resources can help.
https://immattersacp.org/weekly/archives/2023/04/11/5.htm
11 Apr 2023
‘Considerable uncertainty’ surrounds efficacy, safety of analgesics for low back pain
A systematic review and meta-analysis of 98 randomized controlled trials found little high-certainty evidence on the comparative effectiveness and safety of analgesics for acute nonspecific low back pain.
https://immattersacp.org/weekly/archives/2023/03/28/1.htm
28 Mar 2023
Learn the latest on excessive alcohol use, opioid use disorder
This month's issue addresses alcohol use and misuse, prescribing buprenorphine, and improving health care's response to future pandemics.
https://immattersacp.org/archives/2023/03/learn-the-latest-on-excessive-alcohol-use-opioid-use-disorder.htm
1 Mar 2023
Big barrier to buprenorphine removed
The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
https://immattersacp.org/archives/2023/03/big-barrier-to-buprenorphine-removed.htm
1 Mar 2023
Nonopioids effective for acute low back pain, review finds
Myorelaxants and NSAIDs with or without acetaminophen were all effective at reducing pain and disability from acute, nonspecific low back pain lasting less than 12 weeks, according to an analysis of 18 randomized controlled trials, although the authors stressed that medications for this condition should always be a second-line strategy.
https://immattersacp.org/weekly/archives/2023/02/28/1.htm
28 Feb 2023
Overdose risk may be highest in week after hospital discharge for patients on long-term opioids
During the first seven days after hospital discharge, patients prescribed long-term opioid therapy overdosed on opioids at a rate six times higher than in other time periods, a retrospective study in one health system found.
https://immattersacp.org/weekly/archives/2023/01/31/4.htm
31 Jan 2023
More tools available for treating IBS
Irritable bowel syndrome (IBS) is not a new disorder, but physicians' understanding of its pathophysiology and treatment has greatly progressed over the years.
https://immattersacp.org/archives/2023/01/more-tools-available-for-treating-ibs.htm
1 Jan 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2023